130 related articles for article (PubMed ID: 9542514)
1. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours.
Lee CS
Eur J Surg Oncol; 1998 Feb; 24(1):38-42. PubMed ID: 9542514
[TBL] [Abstract][Full Text] [Related]
2. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
Lee CS
Eur J Surg Oncol; 1997 Jun; 23(3):233-7. PubMed ID: 9236898
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours.
Lee CS; Pirdas A
Pathol Res Pract; 1995 Nov; 191(11):1087-91. PubMed ID: 8822109
[TBL] [Abstract][Full Text] [Related]
4. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas-Zivcic A
Pathology; 1994 Oct; 26(4):448-52. PubMed ID: 7892048
[TBL] [Abstract][Full Text] [Related]
5. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
Lee CS; Redshaw A; Boag G
Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876
[TBL] [Abstract][Full Text] [Related]
6. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
7. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas A
Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
9. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
10. Differences in c-fos gene product expression in cancers of the gall-bladder and biliary tract.
Lee CS
Pathol Int; 1996 Oct; 46(10):771-6. PubMed ID: 8916147
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
12. Differences in antigen expression between neoplastic and nonneoplastic gallbladder epithelium. An immunohistochemical study.
Iliopoulos D; Atkinson B; Saul SH; Herlyn M; Rodriguez-Martinez HA; West SL; Maislin G; Soloway RD; Strom BL
Dig Dis Sci; 1993 Jan; 38(1):155-60. PubMed ID: 8420749
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
14. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
15. [Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma].
Zhou YM; Li YM; Cao N; Feng Y; Zeng F
Ai Zheng; 2003 Mar; 22(3):262-5. PubMed ID: 12654182
[TBL] [Abstract][Full Text] [Related]
16. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
Xu LN; Zou SQ; Wang JM
World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
[TBL] [Abstract][Full Text] [Related]
18. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
[TBL] [Abstract][Full Text] [Related]
19. [The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].
Qing D; Xia L; Zhang X
Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):102-4. PubMed ID: 7656696
[TBL] [Abstract][Full Text] [Related]
20. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
